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Summary
Distinct MAP kinase pathways in yeast share several
signaling components [1, 2], including the PAK Ste20
and the MAPKKK Ste11, yet signaling is specific. Mat-
ing pheromones trigger an initial step in which Ste20
activates Ste11 [3], and this requires plasma mem-
brane recruitment of the MAP kinase cascade scaffold
protein, Ste5 [4–7]. Here, we demonstrate an additional
role for Ste5 membrane localization. Once Ste11 is ac-
tivated, signaling through themating pathway remains
minimal but is substantially amplified when Ste5 is re-
cruited to the membrane either by the Gbg dimer or by
direct membrane targeting, even to internal mem-
branes. Ste11 signaling is also amplified by Ste5 olig-
omerization and by a hyperactivating mutation in the
Ste7 binding region of Ste5. We suggest a model in
which membrane recruitment of Ste5 concentrates
its binding partners and thereby amplifies signaling
through the kinase cascade. We find similar behavior
in the osmotically responsive HOG pathway. Remark-
ably, while both pheromone and hyperosmotic stimuli
amplify signaling from constitutively active Ste11, the
resulting signaling output remains pathway specific.
These findings suggest a common mode of regulation
inwhich pathway stimuli both initiate and amplify MAP
kinase cascade signaling. The regulation of rate-limit-
ing steps that lie after a branchpoint from shared com-
ponents helps ensure signaling specificity.
Results and Discussion
In two yeast MAP kinase cascades, the mating and HOG
pathways (Figure 1A), membrane recruitment of a scaf-
fold protein [4, 8] promotes an initial Ste20/ Ste11 ac-
tivation step [3]. Other functional consequences of
membrane recruitment are unexplored, but conceivably
could include enhancement of signaling efficiency or fi-
delity. Theoretically, the sharing of signaling intermedi-
ates among multiple pathways (Figure 1A) could be rel-
atively benign if rate-limiting steps that lie after the
branchpoint were regulated by specific pathway stimuli
(Figure 1B). To evaluate which steps in the mating path-
way are rate limiting, we used hyperactive mutants
(Figure 1C). Constitutively active forms of Cdc42
(CDC42L61; [9]) and Ste20 (STE20DN; [10]) were overex-
pressed (PGAL1), and an activated form of Ste11 (STE11-
4; [3, 11]) was expressed from its native promoter. Each
*Correspondence: peter.pryciak@umassmed.edumutant alone caused minimal signaling compared to si-
multaneous treatment with pheromone (a-factor;
Figure 1C), consistent with previous findings with
STE11-4 [12–14]. For clarity, in the remainder of this
study we refer to this stimulated increase in signaling
beyond that provided by constitutively active pathway
components as ‘‘amplification.’’
While these results suggest regulatable, rate-limiting
steps downstream of Ste11, a caveat of the Ste11-4 mu-
tant is that it may be only partially activated and thus still
regulatable via phosphorylation sites in the Ste11 N ter-
minus [3]. Indeed, signaling by Ste11-4 was strongly re-
duced when these sites were replaced with alanine res-
idues (Ste11-4/Ala3; Figure 1E). To eliminate regulatory
input via these phosphorylation sites, we used the
Ste11-Asp3 mutant, which contains aspartate replace-
ments (Figure 1D) and signals constitutively upon over-
expression [3]. When expressed from its native pro-
moter, the Ste11-Asp3 mutant, like Ste11-4, gave only
mild basal signaling that was still amplified dramatically
by pheromone (Figure 1E, left), as did a combined mu-
tant harboring activating mutations in both regions
(Ste11-4/Asp3). Nevertheless, each activated mutant al-
lowed a robust response to pheromone in ste11D
ste20D cells (Figure 1E, center). Therefore, they bypass
the requirement for Ste20 but not the requirement for
pheromone. The concordant behavior of all activated
mutants suggests that amplification is functionally sep-
arable from regulation of Ste11 activity by phosphoryla-
tion and conformational changes. By means of FACS
analysis of cells containing a PFUS1-GFP reporter (Fig-
ure 1F), we saw no evidence that constitutively active
Ste11 could induce maximum signaling in a minority of
cells, as might accompany switch-like signaling [15,
16]. Instead, STE11-Asp3 caused a relatively uniform
and mild increase in basal signaling, yet conferred ro-
bust pheromone response to ste20D cells. Clearly then,
pheromone modulates signaling efficiency in a way that
is separable from the Ste20 / Ste11 phosphorylation
step.
Though independent of Ste20, pheromone amplifica-
tion of Ste11 signaling required the scaffold protein,
Ste5 (Figure 1E, right), as well as the a-factor receptor
(Ste2) and the Gb (Ste4) subunit (see Figure S1 in the
Supplemental Data available with this article online). Be-
cause pheromone triggers recruitment of Ste5 to the
plasma membrane [4–7], we hypothesized that this
translocation might enhance signaling from activated
Ste11 through the kinase cascade, in addition to pro-
moting the initial Ste20 / Ste11 step. Targeting Ste5
to the plasma membrane via a C-terminal transmem-
brane domain (CTM) causes constitutive, Ste20-depen-
dent signaling [4]. Here, by bypassing Ste20 with the
Ste11-4/Asp3 mutant, we found that fusing Ste5 to the
CTM motif also amplified Ste11 signaling (Figure 2A). In-
terestingly, Ste20-independent amplification was freed
from a localization constraint that normally applies to
Ste20-dependent signaling. This was revealed by fusing
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619Figure 1. Regulation of Signaling Steps that Lie Downstream of Shared Components
(A) MAP kinase cascade pathways with shared and unique components [1, 2, 23]. Activation of the mating and HOG pathways is associated with
membrane recruitment of a scaffold protein (Ste5 or Pbs2) [4, 8]. For simplicity, the activator of Cdc42 (the GEF Cdc24) is not shown.
(B) Alternate views of signaling circuitry. Left: Stimuli act at the beginning of each pathway, increasing signaling through each required step.
Right: Stimuli act in the middle of the pathway, boosting signal transmission from upper to lower steps. The view on the right, in which regulation
occurs after a branchpoint from common components, provides an inherent mechanism for signaling specificity. Previous studies argue that
pheromone stimulates the Ste20/ Ste11 step rather than earlier steps [3, 4, 9]. Results here argue that the signaling output from activated
Ste11 is amplified in a pathway-specific manner.
(C) Constitutive activation of Cdc42, Ste20, and Ste11 yields only minimal signaling that is substantially amplified by pheromone. Wild-type cells
harbored vector, PGAL1-CDC42
L61, or PGAL1-STE20DN, and ste11D cells harbored STE11-4 expressed from its native promoter. For immunoblots
(top), cells also contained a Fus3-myc construct and were treated with 2% galactose for 90 min, with 5 mM a-factor added during the final 15 min.
For transcriptional induction of the FUS1-lacZ reporter construct (bottom), cells were treated with 2% galactose 6 5 mM a-factor for 3 hr; n = 3.
(D) Activation mechanism of wild-type Ste11 (wt) by Ste20 phosphorylation, involving conversion from an autoinhibited (inactive) conformation to
an open (active) conformation. Mutant forms of Ste11 mimic either inactive (Ala3) or active (Asp3, 11-4) states [3, 11].
(E) Activated forms of Ste11 bypass the requirement for Ste20 but not the requirement for pheromone. Ste11 derivatives were expressed from the
native STE11 promoter in the indicated strains, and FUS1-lacZ expression was measured 6 a-factor (5 mM for 2 hr; n = 4).
(F) FACS analysis of cells containing an integrated PFUS1-GFP reporter. The vertical dashed line shows mean basal fluorescence in STE11-WT
cells. STE11-Asp3 does not cause maximal signaling in a minority of cells, but allows ste20D cells to respond to a-factor (aF; 10 mM for 2 hr).
Data in bar graphs show the mean 6 SD.Ste5 to transmembrane domains that localize to internal
membranes such as endoplasmic reticulum (ER) and
Golgi, rather than the plasma membrane (Figure S2).
As found previously [4], Ste20-dependent signaling re-
quired Ste5 to localize to the plasma membrane (Fig-
ure 2A, black bars), where Ste20 itself localizes [9, 10].
But when Ste20 was bypassed with the Ste11-4/Asp3
mutant, membrane localization of Ste5 amplified signal-
ing regardless of the target membrane (Figure 2A, gray
bars).Relatedly, we also found that Gbg could trigger ampli-
fication of Ste11 signaling from internal membranes
(Figure 2B). Transmembrane anchors were attached to
a derivative of the Gg subunit, Ste18, that lacks its native
C-terminal membrane-tethering sequence (Ste18DC;
[4]); these were then cooverexpressed with the Gb sub-
unit (PGAL1-STE4), to activate Gbg without pheromone.
Ste20-dependent signaling (Ste11-WT) required the do-
main that targets the plasma membrane (CTM), whereas
amplification of Ste11 signaling (Ste11-4/Asp3) was
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620Figure 2. Membrane Recruitment of Ste5
Amplifies Signaling through the Kinase Cas-
cade
(A) Membrane targeting of Ste5 amplifies
Ste11 signaling. PGAL1-GFP-STE5 plasmids
were tested for Ste20-dependent signaling
(black bars) or Ste20-independent signaling
(gray bars); n = 6. Localization of each trans-
membrane domain fusion to the plasma
membrane (PM) versus internal membranes
(ER/Golgi) is summarized (see Figure S2).
These experiments used Ste5DN (= D1-214)
to avoid competing plasma membrane-tar-
geting information in the Ste5 N terminus
[7]. Inset: anti-GFP immunoblot of GFP-Ste5
derivatives, in the same left-to-right order as
the bar graph.
(B) Gbg (Ste4 + Ste18) can amplify Ste11 sig-
naling from internal membranes; n = 6.
(C) Comparison of Ste11 amplification by
membrane targeting (Ste5-CTM) and oligo-
merization (Ste5-GST); n = 6. Inset: anti-GFP
immunoblot showing similar expression
levels of different GFP-Ste5 derivatives.
(D) Membrane-targeted Ste5 amplifies sig-
naling by constitutively active Cdc42 and
Ste20. Cells (ste4D ste5D) were induced
with 2% galactose for 90 min prior to immu-
noblot analysis with anti-phospho-p44/42
antibodies. Total Fus3-myc levels were simi-
lar in all samples (not shown). Because
Ste20 is inherently required for the Cdc42 ex-
periments, here we used the Ste5DN-Sed5
fusion, which cannot induce signaling on its
own in STE20+ strains.
(E) Amplification of Cdc42 and Ste20 signal-
ing by Ste5 oligomerization (Ste5-GST) in
ste4D ste5D cells; n = 3.
Data in bar graphs show the mean 6 SD.achieved by targeting Gbg to internal membranes via the
Sec22 and Sed5 domains (Figure 2B). Untargeted
Ste18DC did not amplify Ste11 signaling, suggesting
that binding of cytoplasmic Gbg to Ste5 is not sufficient
and hence that membrane recruitment is required, con-
sistent with the results of direct Ste5 targeting. Together,
our findings indicate that Ste5 membrane recruitment by
Gbg ordinarily serves two roles: the first is to promote
the Ste20 / Ste11 activation step, and the second is
to amplify signaling from active Ste11 through the re-
mainder of the kinase cascade. Presumably, both are
normally triggered at the plasma membrane, but when
the first step is bypassed via preactivated Ste11 mu-
tants, the second step can be promoted by recruiting
Ste5 to any membrane.
The role of membrane localization in Ste11 amplifica-
tion could be an effect of membrane lipids on protein ac-
tivity, or it could reflect the ability of membrane recruit-
ment to concentrate signaling proteins [17]. To test the
latter possibility, we compared membrane localization
with forced oligomerization of Ste5. We found thatfusion of Ste5 to a homodimerizing GST moiety [18–20]
could amplify Ste11 signaling (Figure 2C), though some-
what less potently than Ste5-CTM. Similar results were
reported recently [14]. Control experiments show that
these effects are not simply due to distortion of the
Ste5 C terminus (Figure S3A). Signaling initiated by
Cdc42 and Ste20 was also amplified by membrane tar-
geting (Figure 2D) or dimerization (Figure 2E) of Ste5, re-
vealing that they have cryptic signaling activity that re-
quires amplification to produce significant output.
Importantly, we determined that Ste5-GST amplified
Ste11 signaling in the absence of both Gb (Ste4; Fig-
ure 2C) and a membrane binding domain in the Ste5 N
terminus (Figure S3B), and thus was independent of
the known ability of dimerization to promote Ste5 mem-
brane localization [7, 20]. Conversely, the effect of mem-
brane targeting did not require oligomerization via the
RING-H2 domain [18, 20–22], because this region was
absent in the membrane-targeted Ste5DN derivatives
(Figure 2A). Therefore, dimerization and membrane tar-
geting might act in distinct ways, or in each case the
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621Figure 3. Hyperactive Mutants Suggest that
N- and C-Terminal Domains of Ste5 Promote
Signaling in Distinct Ways
Insets show immunoblots of GFP-Ste5 or
Ste5-GST fusions in the same left-to-right or-
der as the bar graphs.
(A) Ste20-dependent signaling by hyperac-
tive Ste5 mutants. Strong signaling by these
Ste5 derivatives requires fusion to GST [7,
19]. The wild-type (wt) Ste5-GST fusion trig-
gers signaling in STE4+ cells, whereas only
the mutants signal in ste5D ste4D cells, and
this depends on Ste20 (n = 3).
(B) Hyperactive Ste5 mutants can amplify
Ste11 signaling. Cells harbored a STE11 plas-
mid and a PGAL1-GFP-STE5 plasmid; n = 4.
Because these mutants were initially isolated
in a STE5-GST context [19], which itself am-
plifies Ste11 signaling, they were transferred
to a context lacking the GST tag for these ex-
periments.
(C) Amplification by the N-terminal Ste5 mu-
tants correlates with enhanced membrane
binding. Cells harbored a STE11 plasmid
and a PGAL1-GFP-STE5 plasmid; n = 3. Sub-
stitution of Pro44 and Thr52 with hydropho-
bic residues (Leu, Phe) triggers membrane lo-
calization of Ste5 [7]. The stronger amplifying
effects of Thr52 mutations agree with their
stronger membrane association [7].
(D) The ability of Ste5-S770N to amplify Ste11
signaling is independent of N-terminal Ste5
domains involved in membrane binding, Gbg
binding, and oligomerization (see [F]). Cells
harbored a STE11 plasmid and a PGAL1-GFP-
STE5 plasmid; n = 4.
(E) The ability of Ste5-S770N to trigger Ste20-dependent signaling requires the Ste5 N terminus. Cells harbored PGAL1-STE5-GST plasmids; n = 6.
(F) Diagram showing binding domains in Ste5, as well as point mutations and N-terminal deletions analyzed in other panels. PM, plasma mem-
brane binding domain.
Data in bar graphs show the mean 6 SD.pertinent effect may be to promote the colocalization of
multiple scaffold molecules.
Hyperactive Ste5 mutants have been isolated that by-
pass Ste4 (Gb), and the resulting signaling requires
Ste20 ([19] and Figure 3A). We found that these Ste5 mu-
tants (minus the GST tag) also amplified Ste11 signaling
(Figure 3B). Nevertheless, the mutants differentially en-
hanced the two signaling steps: the N-terminal mutant
P44L was strongest when signaling required Ste20
(Figure 3A, black bars [ste4D ste5D]; see also [7, 19]),
whereas the C-terminal mutant S770N was strongest
at Ste11 amplification (Figure 3B). The Ste5 N terminus
contains a membrane binding domain (Figure 3F), and
certain hydrophobic substitutions enhance its mem-
brane affinity, triggering membrane localization and
Ste20-dependent signaling [7]. Accordingly, these
same hydrophobic substitutions (P44L, P44F, T52L,
T52F; [7]) triggered Ste11 amplification (Figure 3C),
whereas others (P44N, T52N, T52H) did not. These re-
sults explain the amplification effect of the N-terminal
Ste5 mutants and provide further evidence that mem-
brane localization amplifies Ste11 signaling.
Unlike the N-terminal mutants, however, the Ste5
C-terminal mutant S770N has no evident effect on local-
ization [7, 19] and yet is especially potent at Ste11 ampli-
fication (Figure 3B). Further suggesting a distinct mech-
anism, the amplifying effect of S770N remained intact
when combined with large deletions (D26-138 andD1-214; Figure 4D) that remove several N-terminal bind-
ing domains (e.g., membrane, Gbg, oligomerization).
Thus, rather than inducing signaling-promoting contacts
between N- and C-terminal domains, as proposed previ-
ously [19], we suggest that S770N may have a relatively
‘‘local’’ effect within Ste5, such as altering Ste7 binding
(see Figure S4). In striking contrast, however, when sig-
naling still required Ste20, the hyperactivity of Ste5-
S770N was entirely dependent on the Ste5 N terminus
(Figure 3E). The simplest explanation for this difference
is that when Ste11 is wild-type, membrane binding by
the Ste5 N terminus is required to promote an initial
low level of Ste20 / Ste11 activation at the plasma
membrane, which is then amplified by Ste5-S770N.
The experiments above show that mating pathway
signaling is buffered against excess activity from
Cdc42, Ste20, and Ste11. We compared this behavior
with the HOG pathway, which shares these same pro-
teins (Figure 1A; [23]). First, the osmotic resistance de-
fect of cells lacking Ste20 could be bypassed by
expressing Ste11-Asp3 from its native promoter (Fig-
ure 4A). Second, Hog1 phosphorylation in cells express-
ing native Ste11-Asp3 was submaximal, and yet was
strongly amplified by the hyperosmotic stimulus (Fig-
ure 4B). This agrees with the fact that Sho1 is required
for osmotic resistance in cells expressing activated
Ste11 [24]. Remarkably, although both mating and os-
motic stimuli could amplify signaling from preactivated
Current Biology
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the proper MAPK (Fus3 or Hog1) was activated (Fig-
ure 4C). Results were similar in ste20D cells, showing
that the ability of each stimulus to activate a unique
MAPK is separable from regulation of the Ste20 /
Ste11 step. Therefore, in addition to sharing protein
components, the mating and HOG pathways share a
similar behavior. In each pathway, activation of the
downstream-most shared component, Ste11, is not
Figure 4. The HOG Pathway Shows Stimulus-Induced Amplification
of Ste11 Signaling
(A) Constitutively active Ste11 (Ste11-Asp3) bypasses the role of
Ste20 in HOG pathway function. Serial dilutions of cells harboring
STE11 plasmids were spotted onto the indicated media and grown
at 30ºC for 2 days (YPD) or 4 days (YPD + 1.2 M NaCl).
(B) HOG pathway signaling by Ste11-Asp3 is amplified by hyperos-
motic stimulation. Cells harboring different STE11 alleles expressed
from their native promoter plus a Hog1-GFP construct were treated6
0.5 M NaCl for 5 min. Hog1 phosphorylation was detected via anti-
phospho-p38 antibodies, and Hog1 levels were detected via anti-
GFP antibodies.
(C) Mating and HOG pathway stimuli trigger signaling in a pathway-
specific manner even when the Ste20/ Ste11 step is bypassed.
Strains expressed Ste11-Asp3 plus either Fus3-myc or Hog1-GFP.
Cells were treated with no stimulus, 10 mM a-factor (15 min), or
0.5 M NaCl (5 min). Levels of Fus3 and Hog1 were detected via
anti-myc and anti-GFP antibodies, respectively. Phosphorylation
was detected via anti-phospho-p44/42 and anti-phospho-p38
antibodies.sufficient for robust signaling. Instead, signaling down-
stream of activated Ste11 is separately boosted by path-
way stimuli, yet specifically directed toward the appro-
priate MAPK.
Given that both mating and HOG pathway stimuli am-
plify Ste11 signaling, it is noteworthy that the scaffolds
for each pathway, Ste5 and Pbs2, are recruited to the
plasma membrane [4, 8]. In each case, this was thought
to promote the Ste20 / Ste11 step, yet our findings
suggest that membrane localization can play an addi-
tional role after Ste11 is activated. Similarly, in the mam-
malian Raf-MEK-ERK cascade, membrane localization
can convert low Raf activity into high signaling output
[16]. Yet in no case is the precise molecular mechanism
known. Membrane lipids could trigger a conformational
change in either the scaffold or one of the kinases. Al-
ternatively, membrane recruitment could amplify signal-
ing via a concentration effect, promoting interactions
among kinases by colocalizing them in a reduced vol-
ume [17, 25]. This model warrants serious consideration,
as it could be broadly applicable and would explain the
similar amplification effects of membrane targeting and
forced dimerization of Ste5. Indeed, membrane recruit-
ment can raise local concentrations by 100- to 1000-
fold [17, 26], which can increase the number of com-
plexes between two proteins when even a moderate
fraction of each (e.g., 10%) is colocalized [17]. The ben-
efits of colocalization are less obvious for scaffolded
pathways, since the kinases are assumed already to
be in close mutual proximity, yet signaling would be en-
hanced under several scenarios: (1) if signaling involves
homodimeric interactions of any of the included compo-
nents (e.g., Ste5-Ste5, Ste11-Ste11, Ste7-Ste7, or Fus3-
Fus3); (2) if only a minority of scaffold proteins in the
cytoplasm have all kinase binding sites occupied simul-
taneously; or (3) if steric hinderance precludes func-
tional interaction between two kinases bound to the
same scaffold molecule, so that ‘‘productive’’ interac-
tions occur preferentially in trans. While the efficiency
relative to activation in cis is unknown, prior studies sug-
gest that kinase activation on Ste5 can occur in trans
[18, 21]. This was taken to suggest a functional role for
Ste5 dimerization, but could be explained equally well
by the concentrating effect of Ste5 membrane recruit-
ment, and without the need for specific Ste5-Ste5 con-
tacts. This view can help reconcile why the Gbg binding
site in Ste5 is required for trans activation [18, 21] and
yet is dispensible when the role of Gbg in recruitment
is bypassed [4, 7, 22], and why Ste5 oligomerization is
not obviously regulated [21, 22], unlike membrane re-
cruitment [4–7].
In conclusion, our findings illustrate how membrane
recruitment of a MAP kinase cascade scaffold protein
triggers both the initiation and amplification of signaling
through the kinase cascade. This relates to examples in
mammalian cells involving membrane translocation of
kinases and scaffolds [16, 27], and where membrane
clustering enhances signaling by preactivated receptor
tyrosine kinases [28]. In addition, our observations re-
veal harmony between the underlying logic of signaling
circuitry in two pathways that use common components
(mating and HOG). In each case, signaling is optimal
only when steps in the middle of the pathway circuit
are stimulated, thus minimizing crosspathway signaling
Membrane Localization and MAP Kinase Signaling
623that might otherwise result from sharing components in
earlier steps. This view is an extension of one proposed
recently based on complementary results [14], which
our work expands by separating amplification from the
Ste20/ Ste11 step, by linking amplification to a stimu-
lus-regulated event (i.e., Ste5 membrane recruitment),
and by uncovering strikingly parallel regulatory behavior
between mating and HOG pathways. Similar strategies
may be employed by other signaling pathways (e.g.,
[29]), and a better understanding of which steps are
rate limiting in vivo may assist computational modeling
of signal transduction [30].
Supplemental Data
Supplemental Data include four figures, two tables, and Supplemen-
tal Experimental Procedures and can be found with this article online
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